Coverage of "Hims & Hers" on Cryptopasta: the stories and the context behind them.
The CFO sold $229,000 in shares just before a key FDA advisory panel meeting on peptide rules, leaving Hims & Hers stock caught between resistance and support amid market uncertainty.
July 23, 2026
